Exo-cis-3,6-epoxy-1-methylhexahydrophthalic anhydride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃类
• 英文名称: Exo-cis-3,6-epoxy-1-methylhexahydrophthalic anhydride
• 英文别名: 2-methyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione
• 化学式: C₉H₁₀O₄
• mdl: MFCD03931373
• 分子量: 182.17
• InChiKey: RJXMWQSSXZMNIT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.777
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS
  申请人：Gasser Robin Beat

  公开号：US20100137294A1

  公开（公告）日：2010-06-03

  The present application discloses the Tv-stp-1 serine/threonine phosphatase gene from Trichostrongylus vitrinus , and compounds that are useful as invertebrate control agents.

  本申请披露了Trichostrongylus vitrinus的Tv-stp-1丝氨酸/苏氨酸磷酸酶基因以及作为无脊椎动物控制剂有用的化合物。
• SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS
  申请人：Zhao Lizhen

  公开号：US20080004440A1

  公开（公告）日：2008-01-03

  A method for treating a scar comprises administering to a scar a pharmaceutically effective amount of one or more blistering agents in a pharmaceutically acceptable carrier.
• COMPOSITIONS AND METHODS FOR THE PROTECTION OF NUCLEOPHILIC GROUPS
  申请人：Mao Fei

  公开号：US20110201010A1

  公开（公告）日：2011-08-18

  The present invention provides compositions, methods, and kits relating to the protection and deprotection of molecules comprising nucleophilic groups, such as the protection and deprotection of thermostable polymerases. Also provided are methods of performing nucleic acid amplification using polymerases protected according to the invention.
• US9222127B2
  申请人：——

  公开号：US9222127B2

  公开（公告）日：2015-12-29
• [EN] SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS<br/>[FR] TRAITEMENT DE CICATRICES À L'AIDE D'INHIBITEURS DE PROTÉINE PHOSPHATASE
  申请人：BIOBOTANIC CORP

  公开号：WO2007149543A2

  公开（公告）日：2007-12-27

  [EN] A method for treating a scar comprises administering to a scar a pharmaceutically effective amount of one or more blistering agents in a pharmaceutically acceptable carrier.
  [FR] L'invention concerne un procédé de traitement d'une cicatrice qui consiste à administrer au niveau de la cicatrice une quantité pharmaceutiquement efficace d'un ou plusieurs agents vésicants dans un vecteur pharmaceutiquement acceptable.